41 – 50 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas.
(
- Contribution to journal › Article
-
Mark
Optogenetics reveal delayed afferent synaptogenesis on grafted human induced pluripotent stem cell-derived neural progenitors.
(
- Contribution to journal › Article
- 2013
-
Mark
Stem cell-based therapy for malignant glioma.
(
- Contribution to journal › Scientific review
-
Mark
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.
(
- Contribution to journal › Article
- 2012
-
Mark
The adult human brain harbors multipotent perivascular mesenchymal stem cells.
(
- Contribution to journal › Article
-
Mark
Rat Multipotent Mesenchymal Stromal Cells Lack Long-Distance Tropism to 3 Different Rat Glioma Models
(
- Contribution to journal › Article
- 2011
-
Mark
Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.
(
- Contribution to journal › Article
-
Mark
Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation.
(
- Contribution to journal › Article
- 2010
-
Mark
Toward Brain Tumor Gene Therapy Using Multipotent Mesenchymal Stromal Cell Vectors.
(
- Contribution to journal › Article
-
Mark
Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.
(
- Contribution to journal › Article